Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Reduction in all-cause mortality and morbidity...
Conference

Reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials

Authors

Young JB; Swedberg K; Dunlap ME; Pfeffer MA; Probstfield JL; Granger CB; McKelvey RS; McMurray JJV; Michaelson EL; Olofsson B

Volume

10

Publisher

Elsevier

Publication Date

August 2004

DOI

10.1016/j.cardfail.2004.06.212

Conference proceedings

Journal of Cardiac Failure

Issue

4

ISSN

1071-9164